LumiraDx (LumiraDx) Other Long-Term Liabilities : $57.9 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Other Long-Term Liabilities?

LumiraDx's other long-term liabilities for the quarter that ended in Jun. 2023 was $57.9 Mil.

LumiraDx's quarterly other long-term liabilities increased from Dec. 2022 ($49.5 Mil) to Mar. 2023 ($52.1 Mil) and increased from Mar. 2023 ($52.1 Mil) to Jun. 2023 ($57.9 Mil).

LumiraDx's annual other long-term liabilities declined from Dec. 2020 ($451.7 Mil) to Dec. 2021 ($10.4 Mil) but then increased from Dec. 2021 ($10.4 Mil) to Dec. 2022 ($49.5 Mil).

LumiraDx Other Long-Term Liabilities Historical Data

The historical data trend for LumiraDx's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Other Long-Term Liabilities Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Other Long-Term Liabilities

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Other Long-Term Liabilities	Get a 7-Day Free Trial								-	-	-	-	-

LumiraDx Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

LumiraDx Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of LumiraDx's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDXF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.